Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease

Fabrizio Villani, Giovanna Viola, Chiara Vismara, Alberto Laffranchi, Anna Di Russo, Simonetta Viviani, Valeria Bonfante

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The aim of the present investigation was to evaluate lung function and the time course of serum concentration of selected cytokines known to be involved in pulmonary fibrosis, in 39 patients with stages IIB, III and IV Hodgkin's disease submitted to intermediate -high dose chemotherapy, (epirubicin, vincristine, cyclophosphamide, etoposide, prednisone) followed by radiotherapy. Lung function tests were performed before, at the end of treatment and after a follow-up of more than 12 months from the end of the combined therapy. Tumor necrosis factor alpha, fibronectin and Interleukins 4, 6 and 8 were determined on serum samples collected at the same time intervals. In the patients, spirometric parameters apparently improved whereas diffusing capacity for CO (DLCO) decreased, TNF-α concentrations constantly decreased, fibronectin and IL-8 showed a tendency to increase, but Interleukins 4 and 6 did not show significant modifications. No significant correlations were observed between the changes of lung function tests and serum cytokine concentrations, probably because cytokine serum levels were not able to reflect events occurring in the alveolar phase.

Original languageEnglish
Pages (from-to)2403-2408
Number of pages6
JournalAnticancer Research
Volume22
Issue number4
Publication statusPublished - 2002

Fingerprint

Hodgkin Disease
Radiotherapy
Cytokines
Drug Therapy
Lung
Respiratory Function Tests
Serum
Interleukin-8
Fibronectins
Interleukin-4
Interleukin-6
Epirubicin
Pulmonary Fibrosis
Vincristine
Etoposide
Carbon Monoxide
Prednisone
Cyclophosphamide
Tumor Necrosis Factor-alpha
Therapeutics

Keywords

  • Chemotherapy
  • Cytokines
  • Pulmonary toxicity
  • Radiotherapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease. / Villani, Fabrizio; Viola, Giovanna; Vismara, Chiara; Laffranchi, Alberto; Di Russo, Anna; Viviani, Simonetta; Bonfante, Valeria.

In: Anticancer Research, Vol. 22, No. 4, 2002, p. 2403-2408.

Research output: Contribution to journalArticle

@article{484c53a34213445e8292747472df85e4,
title = "Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease",
abstract = "The aim of the present investigation was to evaluate lung function and the time course of serum concentration of selected cytokines known to be involved in pulmonary fibrosis, in 39 patients with stages IIB, III and IV Hodgkin's disease submitted to intermediate -high dose chemotherapy, (epirubicin, vincristine, cyclophosphamide, etoposide, prednisone) followed by radiotherapy. Lung function tests were performed before, at the end of treatment and after a follow-up of more than 12 months from the end of the combined therapy. Tumor necrosis factor alpha, fibronectin and Interleukins 4, 6 and 8 were determined on serum samples collected at the same time intervals. In the patients, spirometric parameters apparently improved whereas diffusing capacity for CO (DLCO) decreased, TNF-α concentrations constantly decreased, fibronectin and IL-8 showed a tendency to increase, but Interleukins 4 and 6 did not show significant modifications. No significant correlations were observed between the changes of lung function tests and serum cytokine concentrations, probably because cytokine serum levels were not able to reflect events occurring in the alveolar phase.",
keywords = "Chemotherapy, Cytokines, Pulmonary toxicity, Radiotherapy",
author = "Fabrizio Villani and Giovanna Viola and Chiara Vismara and Alberto Laffranchi and {Di Russo}, Anna and Simonetta Viviani and Valeria Bonfante",
year = "2002",
language = "English",
volume = "22",
pages = "2403--2408",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - Lung function and serum concentrations of different cytokines in patients submitted to radiotherapy and intermediate/high dose chemotherapy for Hodgkin's disease

AU - Villani, Fabrizio

AU - Viola, Giovanna

AU - Vismara, Chiara

AU - Laffranchi, Alberto

AU - Di Russo, Anna

AU - Viviani, Simonetta

AU - Bonfante, Valeria

PY - 2002

Y1 - 2002

N2 - The aim of the present investigation was to evaluate lung function and the time course of serum concentration of selected cytokines known to be involved in pulmonary fibrosis, in 39 patients with stages IIB, III and IV Hodgkin's disease submitted to intermediate -high dose chemotherapy, (epirubicin, vincristine, cyclophosphamide, etoposide, prednisone) followed by radiotherapy. Lung function tests were performed before, at the end of treatment and after a follow-up of more than 12 months from the end of the combined therapy. Tumor necrosis factor alpha, fibronectin and Interleukins 4, 6 and 8 were determined on serum samples collected at the same time intervals. In the patients, spirometric parameters apparently improved whereas diffusing capacity for CO (DLCO) decreased, TNF-α concentrations constantly decreased, fibronectin and IL-8 showed a tendency to increase, but Interleukins 4 and 6 did not show significant modifications. No significant correlations were observed between the changes of lung function tests and serum cytokine concentrations, probably because cytokine serum levels were not able to reflect events occurring in the alveolar phase.

AB - The aim of the present investigation was to evaluate lung function and the time course of serum concentration of selected cytokines known to be involved in pulmonary fibrosis, in 39 patients with stages IIB, III and IV Hodgkin's disease submitted to intermediate -high dose chemotherapy, (epirubicin, vincristine, cyclophosphamide, etoposide, prednisone) followed by radiotherapy. Lung function tests were performed before, at the end of treatment and after a follow-up of more than 12 months from the end of the combined therapy. Tumor necrosis factor alpha, fibronectin and Interleukins 4, 6 and 8 were determined on serum samples collected at the same time intervals. In the patients, spirometric parameters apparently improved whereas diffusing capacity for CO (DLCO) decreased, TNF-α concentrations constantly decreased, fibronectin and IL-8 showed a tendency to increase, but Interleukins 4 and 6 did not show significant modifications. No significant correlations were observed between the changes of lung function tests and serum cytokine concentrations, probably because cytokine serum levels were not able to reflect events occurring in the alveolar phase.

KW - Chemotherapy

KW - Cytokines

KW - Pulmonary toxicity

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0036339029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036339029&partnerID=8YFLogxK

M3 - Article

C2 - 12174934

AN - SCOPUS:0036339029

VL - 22

SP - 2403

EP - 2408

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -